Involvement of ERK/MAPK pathway in megakaryocytic differentiation of K562 cells induced by 3-hydrogenkwadaphnin

Toxicology in Vitro

Volumn 22, Issue 6, 2008, Pages 1503-1510

  Meshkini, Azadeh ^a   Yazdanparast, Razieh ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

3 Hydrogenkwadaphnin; Differentiation; ERK MAPK; K562; Leukemia

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 HYDROGENKWADAPHNIN; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; DITERPENE; INOSINATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DENDROSTELLERA LESSERTII; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEGAKARYOCYTE; NONHUMAN; POLYPLOIDY; THYMELAEACEAE; UPREGULATION;

CELL DIFFERENTIATION; CYCLIN D1; DITERPENES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOBLOTTING; K562 CELLS; MEGAKARYOCYTES; THYMELAEACEAE; TIME FACTORS; UP-REGULATION;

DENDROSTELLERA LESSERTII; THYMELAEACEAE;

EID: 49149095762     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.05.005     Document Type: Article

References (47)

1. Asada M., Yamada T., Fukumuro K., and Mizutani S. p21Cip1/WAF1 is important for differentiation and survival of U937 cells. Leukemia 12 (1998) 1944-1950
2. Biggs J.R., Kudlow J.E., and Kraft A.S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemia cells. Journal of Biological Chemistry 271 (1996) 901-906
3. Burger S.R., Zutter M.M., Sturgill-Koszycki S., and Santoro S.A. Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells. Experimental Cell Research 202 (1992) 28-35
4. Chang B.D., Broude E.V., Fang J., Kalinichenko T.V., Abdryashitov R., Poole J.C., and Roninson I.B. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19 (2000) 2165-2170
5. Collart F.R., and Huberman E. Expression of IMP dehydrogenase in differentiating HL-60 cells. Blood 75 (1990) 570-576
6. Copland M., Jorgensen H.G., and Holyoake T.L. Evolving molecular therapy for chronic myeloid leukaemia - are we on target?. Hematology 10 (2005) 349-359
7. Dulic V., Stein G.H., Far D.F., and Reed S.I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role in the G2/M-phase transition. Molecular and Cell Biology 18 (1998) 546-557
8. Eriksson A.C., and Whiss P.A. Measurement of adhesion of human platelets in plasma to protein surfaces in microplates. Journal of Pharmacological and Toxicological Methods 52 (2005) 356-365
9. 1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells. Experimental Cell Research 304 (2005) 175-186
10. Giltay J.C., Brinkman H.J., Modderman P.W., Tetteroo P.A., and van Mourik J.A. Glycoproteins IIb and IIIa in K562 cells. Blood 71 (1988) 1171-1172
11. Gordon M.Y., Dowding C.R., Riley G.P., Goldman J.M., and Greaves M.F. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328 (1987) 342-344
12. Hait W.N., Choudhury S., Srimatkandada S., and Murren J.R. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents. The Journal of Clinical Investigation 91 (1993) 2207-2215
13. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., Beach D., and Lassar A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267 (1995) 1018-1021
14. Hartwell L.H. Cell cycle control and cancer. Science 266 (1994) 1821-8128
15. Hu X., Moscinski L.C., Valkov N.I., Fisher A.B., Hill B.J., and Zuckerman K.S. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. Cell Growth and Differentiation 11 (2000) 191-200
16. Inai K., Tsutani H., Yamauchi T., Fukushima T., Iwasaki H., Imamura S., Wano Y., Nemoto Y., Naiki H., and Ueda T. Differentiation induction in non-lymphocytic leukemia cells upon treatment with mycophenolate mofetil. Leukemia Research 24 (2000) 761-768
17. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., and Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9 (1994) 3397-3406
18. Kikuchi J., Furukawa Y., Iwase S., Terui Y., Nakamura M., Kitagawa S., Kitawaga M., Komatsu N., and Miura Y. Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: involvement of cyclin-dependent kinase inhibitor p21 in polyploidization. Blood 89 (1997) 3980-3990
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
20. Matsumura I., Ishikawa J., Nakajima K., Oritani K., Tomiyama Y., Miyagawa J., Kato T., Miyazaki H., Matsuzawa Y., and Kanakura Y. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Molecular and Cellular Biology 17 (1997) 2933-2943
21. Meshkini A., and Yazdanparast R. Induction of megakaryocytic differentiation in chronic myelogenous leukemia cell K562 by 3-hydrogenkwadaphnin. Journal of Biochemistry and Molecular Biology 40 (2007) 944-951
22. Miyazaki R., Ogata H., and Kobayashi Y. Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation. Annals of Hematology 80 (2001) 284-291
23. Molla A., Mossuz P., and Berthier R. Extracellular matrix receptors and the differentiation of human megakaryocytes in vitro. The Leukemia Lymphoma 33 (1999) 15-23
24. Moosavi A.M., Yazdanparast R., and lotfi A. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5′-triphosphate-mediated terminal erythroid differentiation of K562 cells. International Journal of Biochemistry and Cell Biology 39 (2007) 1685-1697
25. Moosavi M.A., Yazdanparast R., Sanati M.H., and Nejad A.S. 3-Hydrogenkwadaphnin targets inosine 5′-monophosphate dehydrogenase and triggers post-G1 arrest apoptosis in human leukemia cell lines. International Journal of Biochemistry and Cell Biology 37 (2005) 2366-2379
26. Murphy L.O., and Blenis J. MAPK signal specificity: the right place at the right time. Trends in Biochemical Science 31 (2006) 268-275
27. Nagata Y., Takahashi N., Davis R.J., and Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92 (1998) 1859-1869
28. Niculescu III A.B., Chen X., Smeets M., Hengst L., Prives C., and Reed S.I. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Molecular and Cellular Biology 18 (1998) 629-643
29. mapk are required for fibroblast proliferation. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 8319-8323
30. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., Bradley A., Olson E.N., Harper J.W., and Elledge S.J. p53-Independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267 (1995) 1024-1027
31. Pendergast A.M., Quilliam L.A., Cripe L.D., Bassing C.H., Dai Z., Li N., Batzer A., Rabun K.M., Der C.J., and Schlessinger J. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75 (1993) 175-185
32. Platanias L.C. Map kinase signaling pathways and hematologic malignancies. Blood 101 (2003) 4667-4679
33. Pumiglia K.M., and Decker S.J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 448-452
34. Qiu M.S., and Green S.H. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9 (1992) 705-717
35. Racke F.K., Lewandowska K., Goueli S., and Goldfarb A.N. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. Journal of Biological Chemistry 272 (1997) 23366-23370
36. Rojnuckarin P., Drachman J.G., and Kashunsky K. Thrombopoetin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood 94 (1999) 1273-1282
37. Rouyez M.C., Boucheron C., Gisselbrecht S., Dusanter-Fourt I., and Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Molecular and Cellular Biology 17 (1997) 4991-5000
38. Sadeghi H., and Yazdanparast R. Isolation and structure elucidation of a new potent anti-neoplastic diterpene from Dendrostellera lessertii. American Journal of Chinese Medicine 33 (2005) 831-837
39. Scott R.E., Florine D.L., Willi Jr. J.J., and Yun K. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD. Proceedings of the National Academy of Sciences of the United States of America 79 (1982) 845-849
40. Sharrocks A.D. Cell cycle: sustained ERK signalling represses the inhibitors. Current Biology 16 (2006) 540-542
41. Skorski T., Bellacosa A., Nieborowska-Skorska M., Majewski M., Martinez R., Choi J.K., Trotta R., Wlodarski P., Perrotti D., Chan T.O., Wasik M.A., Tsichlis P.N., and Calabretta B. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO Journal 16 (1997) 6151-6161
42. Spira A.I., and Carducci M.A. Differentiation therapy. Current Opinion in Pharmacology 3 (2003) 338-343
43. Uchimaru K., Taniguchi T., Yoshikawa M., Fujinuma H., Fujita T., and Motokura T. Growth arrest associated with 12-o-tetradecanoylphorbol-13-acetate-induced hematopoietic differentiation with a defective retinoblastoma tumor suppressor-mediated pathway. Leukemia Research 22 (1998) 413-420
44. Vitrat N., Cohen-Solal K., Pique C., Le Couedic J.P., Norol F., Larsen A.K., Katz A., Vainchenker W., and Debili N. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 91 (1998) 3711-3723
45. Wilhide C.C., Van Dang C., Dipersio J., Kenedy A.A., and Bray P.F. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood 86 (1995) 294-304
46. Zimmet J., and Ravid K. Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Experimental Hematology 28 (2000) 3-16
47. Zutter M.M., Painter A.D., and Yang X. The megakaryocyte/platelet-specific enhancer of the alpha2beta1 integrin gene: two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade. Blood 93 (1999) 1600-1611